News - Lymphoma Canada

News Research

pCODR Final Recommendation Issued for ibrutinib (Imbruvica) for Mantle Cell Lymphoma (MCL)

On July 19, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…

adminDecember 16, 2016

News Research

Health Canada Approves Venetoclax for CLL Patients With 17P deletion or if No Other Treatment Options are Available

Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for VENCLEXTA™ (venetoclax), a…

adminDecember 16, 2016

News Research

Lymphoma Canada 2016 Research Fellowship Award

Lymphoma Canada is pleased to award its 2016 Research Fellowship to Dr. Anja Mottok, a…

adminAugust 15, 2016

News

Creighton Classic – Par for the Cure – Golf Tournament

THE CREIGHTON CLASSIC - PAR FOR THE CURE- GOLF TOURNAMENT EAGLES NEST GOLF CLUB 10,000 Duﬀerin…

adminJuly 27, 2016

News

CLL/SLL Patient Survey

If you have CLL or SLL and have been treated with venetoclax you can help…

adminJune 10, 2016

News

Tired of Cancer App

A unique app has been developed to help you: the Tired of Cancer app. The…

adminMay 18, 2016

News Presentations

Coping with Cancer – Mindfulness Webinar

Linda Morinello discusses the benefits and teaches you simple mindfulness methods that you can incorporate.

adminApril 27, 2016

News

Waldenstrom’s Macroglobulinemia Patient & Caregiver Surveys

If you have Waldenstrom’s Macroglobulinemia (WM) or you are a caregiver of a patient with…

adminApril 7, 2016

News Research

Health Canada Approves ibrutinib for Waldenström’s Macroglobulinemia

Health Canada has issued a Notice of Compliance (NOC) for ibrutinib (Imbruvica®), a promising oral…

adminApril 6, 2016

News

CLL Patient Survey

Lymphoma Canada is preparing submissions to the panCanadian Oncology Drug Review (pCODR) for: Ibrutinib (Imbruvica)…

adminApril 6, 2016

Mon	Tue	Wed	Thu	Fri	Sat	Sun
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28

News & Media

pCODR Final Recommendation Issued for ibrutinib (Imbruvica) for Mantle Cell Lymphoma (MCL)

Health Canada Approves Venetoclax for CLL Patients With 17P deletion or if No Other Treatment Options are Available

Lymphoma Canada 2016 Research Fellowship Award

Creighton Classic – Par for the Cure – Golf Tournament

CLL/SLL Patient Survey

Tired of Cancer App

Coping with Cancer – Mindfulness Webinar

Waldenstrom’s Macroglobulinemia Patient & Caregiver Surveys

Health Canada Approves ibrutinib for Waldenström’s Macroglobulinemia

CLL Patient Survey

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Join Our Mailing List